SCHEMBL909995

SCHEMBL909995

CC1(C)CC(/C(C(=O)O)=C(/C(=O)O)C2CC(C)(C)N(Cc3ccccc3)C(C)(C)C2)CC(C)(C)N1Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AMPD2 Q01433 3/20 0.43
MEN1 O00255 1/20 0.40
TSHR P16473 1/20 0.40
KMT2A Q03164 1/20 0.40
S1PR1 P21453 1/20 0.40
S1PR5 Q9H228 1/20 0.40
TMEM97 Q5BJF2 2/20 0.40
SIGMAR1 Q99720 2/20 0.40
GAA P10253 1/20 0.40
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
ELANE P08246 1/20 0.39
BRD4 O60885 1/20 0.39
GRM6 O15303 1/20 0.39
HSD11B1 P28845 1/20 0.38
ABL1 P00519 1/20 0.38
RIN1 Q13671 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL909996 1.00 AMPD2 (0.43) AMPD2MEN1TSHRKMT2AS1PR1
SCHEMBL995046 0.82 DRD2 (0.39) AMPD2MEN1TSHRKMT2AS1PR1
SCHEMBL6904601 0.82 DRD2 (0.39) AMPD2MEN1TSHRKMT2AS1PR1
SCHEMBL9514866 0.81 AMPD2 (0.40) AMPD2MEN1TSHRKMT2AS1PR1
Acetic Acid SCHEMBL9813576 0.80 AMPD2 (0.47) AMPD2MEN1TSHRKMT2ATMEM97
SCHEMBL39509 0.79 KMT2A (0.44) AMPD2MEN1TSHRKMT2ASIGMAR1
SCHEMBL28507735 0.78 GAA (0.44) AMPD2KMT2ASIGMAR1GAAKDM4E
Succinic Acid SCHEMBL11829402 0.78 AMPD2 (0.42) AMPD2MEN1KMT2AGAAELANE
SCHEMBL11046592 0.78 AMPD2 (0.42) AMPD2MEN1TSHRKMT2ATMEM97
Ammonia Solution, Strong SCHEMBL8576793 0.78 KMT2A (0.43) AMPD2MEN1TSHRKMT2ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461235-B2 Use of polymer powder containing UV absorber for the stabilisation of polymers against the effects of UV radiation BASF SE (DE) 2013-06-11 US disclosed
US-7935663-B2 From hindered amine, a molybdenum source, and water, the reaction product of a fatty oil with a multifunctional amine and water, or a diol and water; unusually strong antioxidant, excellent antifriction properties to lubricants R. T. VANDERBILT COMPANY, INC. (US) 2011-05-03 US disclosed
US-7875579-B2 Lubricating base oil, an oil-soluble metal compound of molybdenum, tungsten, titanium or boron, and an oil-soluble first hindered amine; synergistically giving enhanced antioxidant protection R.T. VANDERBILT COMPANY, INC. (US) 2011-01-25 US disclosed
EP-1892261-B1 Utilisation of polymer powder containing UV absorber for stabilising polymers against the effects of UV rays BASF SE (DE) 2010-08-18 EP disclosed
US-20100190929-A1 USE OF POLYMER POWDER CONTAINING UV ABSORBER FOR THE STABILISATION OF POLYMERS AGAINST THE EFFECTS OF UV RADIATION BASF AKTIENGESELLSCHAFT (DE) 2010-07-29 US disclosed
US-7728057-B2 Use of polymer powder containing UV absorber for the stabilisation of polymers against the effects of UV radiation BASF AKTIENGESELLSCHAFT (DE) 2010-06-01 US disclosed
US-20090312464-A1 Stabilizer mixtures GUGUMUS FRANCOIS 2009-12-17 US disclosed
EP-1565522-B1 USE OF POLYMER POWDER CONTAINING UV ABSORBER FOR THE STABILISATION OF POLYMERS AGAINST THE EFFECTS OF UV RADIATION BASF SE (DE) 2009-10-14 EP disclosed
US-20080220999-A1 NOVEL MOLYBDENUM COMPOUNDS R.T. VANDERBILT COMPANY, INC. (US) 2008-09-11 US disclosed
US-20080221000-A1 LUBRICANT ANTIOXIDANT COMPOSITIONS CONTAINING A METAL COMPOUND AND A HINDERED AMINE R.T. VANDERBILT COMPANY, INC. (US) 2008-09-11 US disclosed
EP-0290391-A2 Polyolefines stabilized against light degradation CIBA-GEIGY AG (CH) 1988-11-09 EP disclosed
EP-0114784-B1 ELECTRON-BEAM CURING METHOD FOR COATINGS CIBA-GEIGY AG (CH) 1988-06-01 EP disclosed
EP-0255481-A1 Process for the photochemical stabilisation of a fibrous polyamide material and its mixtures with other fibres CIBA-GEIGY AG (CH) 1988-02-03 EP disclosed
EP-0245204-A1 Process for the photochemical stabilization of undyed and dyed fibrous polyamide material and its mixture with other fibres CIBA-GEIGY AG (CH) 1987-11-11 EP disclosed
EP-0237485-A2 Stabilized compositions of rigid PVC CIBA-GEIGY AG (CH) 1987-09-16 EP disclosed
EP-0226538-A2 Light stabilized polymer microparticles CIBA-GEIGY AG (CH) 1987-06-24 EP disclosed
EP-0083308-B1 PROCESS FOR STABILISING FUNGICIDES CIBA-GEIGY AG (CH) 1986-03-05 EP disclosed
US-4511596-A 2,2,6,6-TETRAALKYLPIPERIDINE DERIVATIVES AS CURING PROMOTERS CIBA-GEIGY CORPORATION (US) 1985-04-16 US disclosed
EP-0114784-A2 Electron-beam curing method for coatings CIBA-GEIGY AG (CH) 1984-08-01 EP disclosed
EP-0083308-A1 Process for stabilising fungicides CIBA-GEIGY AG (CH) 1983-07-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080220999-A1 NOVEL MOLYBDENUM COMPOUNDS MGLL, ALOX5, DAGLA AMPD2 2438/4885MEN1 1895/4885TSHR 4794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.